The Biodiversity Consultancy Pharmaceutical
Where business and nature thrive
Where is your company on its nature journey?
Nature is Fundamental to Business
Pharmaceutical companies rely on nature for critical resources—from active ingredients and raw materials to ecosystem services that sustain production. As biodiversity declines and ecosystems degrade, risks to supply continuity, R&D pipelines, and regulatory compliance can become increasingly material, jeopardising business resilience, investments, and reputation. Yet significant opportunities exist: by integrating nature into strategic planning, forward-thinking companies can mitigate risk and unlock value through innovation, efficiency, stakeholder trust, and long-term sustainability.
thebiodiversityconsultancy.com
The Biodiversity Consultancy (TBC) brings proven, trusted expertise in supporting companies through every stage of their nature journey, from discovery to implementation:
STAGE
TYPICAL ACTIVITIES
BENEFITS TO THE BUSINESS
TBC helps businesses understand their nature-related risks and opportunities, build internal awareness, and establish the governance and data needed to begin their nature journey.
Nature risk screening of dependencies, impacts, risks, and opportunities (DIROs) Determine regulatory materiality thresholds Stakeholder engagement Baseline assessments Capacity building
Understand key nature risks and opportunities and data dependencies Gain stakeholders’ insights and build internal capacity Confidence to make public statements and enrol in industry nature initiatives
Activation
Understand key risks and opportunities
TBC helps develop actionable nature
Sector and location-specific materiality assessments Target setting Roadmap development Policy and strategy design Forward-looking scenario planning for financial materiality Nature disclosures (e.g., TNFD)
Detailed mapping of material nature risks and opportunities to inform business decision-making Use of science-based targets and KPIs that are aligned with industry best practice Strategic roadmap to lead nature integration Enhanced confidence to make public statements, commitments and disclosures Implementation plans and operational guidance approved and deployed Nature performance dashboards/ reports in place to inform decision-making Nature considerations integrated into company decision-making (including differentiated risk assumptions) Protocols in place to make corporate nature strategies living documents
strategies aligned with global frameworks, such as the TNFD and SBTN, that are tailored to the business and aligned with regulatory and market expectations.
Transition
Turning insight into strategy
TBC supports the integration of nature into core business functions, reporting, and decision making to drive long term value and resilience.
Nature strategy implementation Year-on-year measurement, monitoring and reporting of nature-related KPIs Screening methods for nature-related risks among suppliers and new acquisitions Cross-functional integration of nature across business units
Integration
Embedding nature into business
The Biodiversity Consultancy brings deep, hands-on experience in shaping globally recognised biodiversity reporting standards—expertise we now apply to help our clients lead with confidence and credibility.
A leading voice in shaping nature standards and metrics
The Biodiversity Consultancy combines deep nature expertise with hands-on experience supporting pharmaceutical companies. We take a pragmatic approach to navigating biodiversity challenges within complex value chains and regulatory environments. Our work helps businesses to understand nature-related impacts and dependencies, identify material risks and opportunities, and design nature-related strategies and targets that reinforce their mission to deliver healthcare innovation and improve wellbeing—leveraging existing efforts for maximum impact. A trusted strategic advisor of pharmaceutical clients, driven by an evidence-based approach
CASE STUDIES
What?
How?
Client Value?
United States Pharmaceutical Company
The client requested support to establish a robust and defensible approach for assessing and reporting on nature-related impacts, tailored to their operational context. A dependency and impact (I&D) assessment was conducted across direct operations and supply chains, complemented by a location-based assessment to identify sites in water-stressed or ecologically sensitive areas. These insights informed a TNFD-aligned risk and opportunity register, with the top three priority risks qualitatively assessed under TNFD scenarios and adapted to the client’s context. Internal stakeholder consultations were held to define ambition, prioritise key risks, and identify critical touchpoints with nature across the value chain. Findings from this structured, LEAP-aligned process guided the drafting of a TNFD-aligned disclosure report, helping the client understand potential responses to limit harm to nature, mitigate future risk, and prepare for evolving regulatory and market expectations.
The engagement provided the client with a clear understanding of their nature-related dependencies, impacts, risks, and opportunities, alongside an evidence-based roadmap of actions to prepare for TNFD-aligned disclosures, mitigate risk, and enhance understanding of key touchpoints with nature. By combining assessment, calibration to client’s operational context, and ongoing engagement throughout the process, the approach ensured insights were robust, relevant, and understood as they were developed. The outputs also helped the client identify the teams within the business to engage, supporting pragmatic action and preparation for evolving regulatory and market expectations.
Supported the development of a TNFD-aligned approach for assessing and reporting on nature-related risks.
Activation
Transition
What?
How?
Client Value?
European Union Pharmaceutical Company
Following an initial TNFD assessment, the client requested a review of their existing biodiversity and sustainability work to support the co-development of an overarching Biodiversity Strategy. The engagement focused on defining a clear set of science-based biodiversity targets aligned with material environmental topics, ensuring coherence with ongoing sustainability initiatives, and identifying practical actions to advance nature-related commitments. The client’s TNFD report and sustainability strategy were reviewed, with practical recommendations provided to enhance the approach to biodiversity. Collaborative workshops with key internal stakeholders were facilitated to build consensus on ambition, targets, and actionable steps, ensuring alignment with broader sustainability workstreams. The outcomes were formalised into a draft Biodiversity Strategy, including clear, evidence-based actions and an executive summary to support senior leadership engagement. The client required a consistent, operational approach to track progress toward their nature commitments, support strategic decision-making, and meet regulatory and disclosure requirements (e.g., CSRD, EUDR). A Nature Impact Measurement Framework was co-designed covering ten internal targets across core workstreams – including water, land, and biodiversity – spanning both operations and supply chains. The framework applied the Pressure–State–Response and SBTN AR³T models to link actions to outcomes, focusing on pragmatic, decision-useful metrics addressing the client’s most material impacts. The work was delivered through an iterative, workshop-based process with client teams to define success, select aligned metrics, and develop a phased implementation roadmap consistent with leading global nature frameworks. This approach ensured the framework was tailored to the client’s strategic priorities and operational realities, supporting both decision-making and future reporting requirements.
The engagement provided the client with a clear, actionable roadmap to advance biodiversity initiatives, integrating science-based targets with internal priorities and material environmental topics. The highly collaborative, co-development approach supported consensus-building across internal stakeholders and clarified ambition and targets, while the expert review of existing strategies ensured biodiversity was coherently integrated within ongoing sustainability initiatives. The resulting Biodiversity Strategy positioned biodiversity as a strategic pillar within the broader sustainability agenda, with a clear set of targets agreed with senior leadership. The engagement delivered a fully defined Nature Impact Measurement Framework with clear metrics, target definitions, and a phased roadmap linking near-term actions to the client’s ambitions. By co-designing the framework through an iterative, workshop-based approach, the client gained a robust, evidence-based framework that translates strategy into actionable metrics while building internal understanding and ownership. The framework operationalises the client’s strategic approach to nature, strengthens readiness for compliance and reporting, embeds nature into enterprise risk management, and provides a robust evidence base to prioritise investments. By focusing on metrics that drive action rather than reporting alone, the framework offers a practical, actionable system to track progress credibly, enhance resilience, and support long-term value creation.
Supported the co-develop- ment of a global Biodiversi- ty Strategy.
Transition
Global Pharmaceutical Company
Supported the develop- ment of a Nature Impact Measurement Framework.
Transition
Integration
Contact the team For more information about our services
Lauren Weatherdon, MSc Business Director, Nature Services lauren.weatherdon @thebiodiversityconsultancy.com
Page 1 Page 2 Page 3 Page 4www.thebiodiversityconsultancy.com
Made with FlippingBook flipbook maker